CDKN1B and osteosarcoma: Previous studies have shown that miR-221-3p could suppress the expression of cyclin-dependent kinase inhibitor 1B (CDKN1B) directly [17]; Similarly, M2 macrophage-derived miR-221-3p plays an important role in osteosarcoma [18].